We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

GSK

18 Jul 2022 18:00

RNS Number : 8801S
FTSE Russell
18 July 2022
 

 

 

Further to the FTSE notice released on 11 July 2022 in relation to GSK (UK): Demerger of Haleon (UK), please note the index changes as a result of the ranking for the removal of the smallest constituent from the fixed indices.

 

Please see the updated notice below:

 

GSK (UK): Demerger of Haleon (UK) - UpdateChanges in FTSE UK Index Series

18 July 2022

Further to the FTSE Russell notices released on 15 June 2022 and 11 July 2022 and following the demerger of Haleon (UK, constituent) from GSK (UK, constituent) and related re-ranking, please see details of affected indexes and effective dates below:

 

Harbour Energy (UK, BMBVGQ3) will be deleted from the FTSE 100 index and added to the FTSE 250 Index.

 

Hochschild Mining (UK, B1FW502) will be deleted from the FTSE 250 index and added to the FTSE SmallCap Index.

 

All changes are effective from 21 July 2022.

 

Full details of index changes are available on the FTSE Russell website.

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1440

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2022 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSQVLFFLDLZBBZ

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.